DataMeds AI, Tollo Health launch Health Lives Here app with NFL Alumni Health

DataMeds AI and Tollo Health have launched the Health Lives Here mobile app to support GLP-1 users with telehealth, pharmacy access and nutrition tools, with NFL Alumni Health helping drive awareness. The companies plan to expand the platform into Long COVID and cancer care next, while building a broader pharmacy and provider network.

Why it matters: - The launch ties telehealth, pharmacy fulfillment, nutrition products and health tracking into one consumer app. - The companies are targeting GLP-1 users first, then plan to expand to people with Long COVID in the fourth quarter of 2026 and cancer patients after that. - The platform is being positioned for underserved and rural communities, where access to care and pharmacy services can be limited.

What happened: - DataMeds AI and Tollo Health announced the launch of the Health Lives Here mobile application. - NFL Alumni Health, the health-focused division of the National Football League Alumni Association, is driving marketing for the app. - The launch also marks the start of a national Health Lives Here healthcare network built from independent pharmacies in Corexa Health’s network. - Moose Pharmacy of Concord in Concord, N.C., is the first Health Lives Here pharmacy. - DataMeds AI is headquartered in Tampa, Fla.

The details: - The app offers in-app telemedicine with asynchronous and synchronous consultations with licensed physicians for GLP-1 therapies, when clinically appropriate. - Corexa Health offers cash-pay access to FDA-approved branded GLP-1 receptor agonist medications through the app. - Patients can use a new telehealth prescription or transfer a prescription from another pharmacy. - Corexa can deliver prescriptions directly to patients’ homes. - Patients can also route prescriptions to a local pharmacy of their choosing if Corexa is not their preferred option. - The app lets users buy Tollo Health products marketed by Corexa, including Forzet, a medical food for dietary management of muscle loss associated with weight-loss therapies, without a prescription. - Corexa also markets Galectovid and Tollovid, both available without a prescription. - The app integrates wearables data from Apple Watch, Samsung Galaxy Watch, WHOOP and Oura Ring so users can view activity, sleep and other metrics in one place. - The behavioral health tools include an AI health coach, activity logs and an AI chatbot. - The AI chatbot is designed to detect crisis language and direct users to the 988 Suicide & Crisis Lifeline and emergency resources. - The app also tracks sleep, movement and mood over time. - Through the Helomics acquisition, the app will soon support direct-to-consumer lab tests where allowed by law. - Users will be able to order tests for in-home or at-the-pharmacy sample collection. - Results will appear in the app and can be tracked over time with repeat testing. - Physicians will also be able to prescribe tests to be run at Helomics for general health, Long COVID or cancer. - Helomics is expanding its test menu and has a reference lab agreement with a large national diagnostic testing company. - The companies also plan a digital twin feature for 2027 that would let users build a full health profile in the app. - The planned profile would include medical records, test results, wearables data, dietary supplement use, nutritional data and mental health history. - The companies intend to put health data on a proprietary blockchain and give users control over access and optional participation in de-identified data sharing. - A provider network is also planned for 2027. - The app is available for Apple devices and Android devices. - More information is available at the company's announcement, Tollo Health's website, the patient access initiative and the mobile application site.

Between the lines: - The launch shows DataMeds AI and Tollo Health trying to build a closed-loop care model that connects telehealth, dispensing, diagnostics and consumer health data. - The NFL Alumni Health partnership gives the campaign a recognizable outreach channel that could help with trust and awareness. - The focus on pharmacy access, wearables and behavioral health suggests the companies are aiming beyond a single prescription workflow. - The planned blockchain and digital twin features point to a longer-term strategy centered on patient-controlled data and personalized care.

What's next: - The companies plan to broaden the app’s target population to Long COVID patients in Q4 2026. - They then intend to expand the app to cancer patients. - Helomics is preparing to add more testing options. - The digital twin and provider network features are slated to come in 2027. - The national Health Lives Here pharmacy network is expected to keep expanding from Corexa’s independent pharmacy base.

The bottom line: - DataMeds AI and Tollo Health are using Health Lives Here to bundle care access, pharmacy fulfillment and data tracking into one platform, with expansion plans that stretch well beyond GLP-1 support.